PMID: 2124670Oct 1, 1990Paper

Low-dose oral administration of human interferon alpha can control the development of Theileria parva infection in cattle

Parasitology
A S YoungC Burns

Abstract

Two natural human interferon alpha preparations, (nHuIFN-alpha [Cantell]) and (nHuIFN-alpha [ISI]), were used for the oral treatment of cattle experimentally infected with Theileria parva parva. In the first experiment, 8 Friesian bulls were inoculated with a 1 in 10 dilution of a sporozoite stabilate of T.p. parva (Marikebuni) stock. Four of the cattle were treated daily with 1 international unit/kg body weight (i.u./kg bwt) of nHuIFN-alpha (Cantell) from day -2 to day 8 p.i. None of the 4 calves given IFN developed clinical theileriosis, but 3 of the 4 control calves died of theileriosis while the fourth had a mild infection. Three of 4 treated calves and the 1 surviving control calf developed a detectable antibody response to T.p. parva schizont antigen but, on challenged with a 10-fold higher dose of stabilate, the surviving control animal and only 1 of the 4 treated calves proved to be immune. In a second experiment, 4 groups of 4 calves were inoculated with the same stabilate dilution. Three treatment groups were given either 1 i.u. nHuIFN-alpha (Cantell), 1 i.u. nHuIFN-alpha (ISI), or 10 i.u. nHuIFN-alpha (ISI)/kg bwt from day -2 to day 8 p.i. once daily and the fourth group were controls. Clinical theileriosis occurred ...Continue Reading

References

Oct 1, 1990·Molecular Immunology·J D Young, T M Young
Feb 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R QuesadaJ U Gutterman
Jan 1, 1987·Annual Review of Biochemistry·S PestkaC E Samuel
Oct 1, 1987·Journal of Interferon Research·R A DiezE Falcoff
Oct 1, 1988·Veterinary Immunology and Immunopathology·S KrakowkaS S Ringler
Nov 1, 1986·The American Journal of Medicine·M S Roth, K A Foon
Dec 1, 1985·Drug Intelligence & Clinical Pharmacy·C M Balmer
Apr 15, 1986·Cancer·S CastaigneL Degos
Oct 1, 1974·Experimental Parasitology·D E RadleyR E Purnell
Jul 1, 1973·The Journal of General Virology·K Cantell, L Pyhälä
Jan 1, 1981·Methods in Enzymology·K CantellV Koistinen
Feb 1, 1981·Journal of Interferon Research·M Wiranowska-Stewart
Jan 1, 1982·Journal of Interferon Research·O NakamuraH Machida
Jan 1, 1983·Cancer Immunology, Immunotherapy : CII·C Jarstrand, S Einhorn
Apr 1, 1983·Parasitology·D A StaggT T Dolan
Feb 1, 1984·International Journal for Parasitology·T T DolanK Soulsby
Oct 1, 1982·Journal of Learning Disabilities·A J Harris
Sep 12, 1957·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·A ISAACS, J LINDENMANN
Jun 1, 1986·Parasitology Today·J M Kelly

❮ Previous
Next ❯

Citations

Apr 1, 1995·Veterinary Immunology and Immunopathology·J M CumminsD P Hutcheson
Mar 21, 1998·International Journal for Parasitology·F E Cox
Jun 7, 2000·Pharmaceutical Science & Technology Today·M W Beilharz
Feb 13, 2003·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Staley A Brod
Sep 7, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·W A Tompkins
Sep 7, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·S A Brod
Sep 7, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·J M CumminsS Krakowka
May 6, 1998·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·S ShiozawaK Shiozawa
Oct 22, 1998·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Y NagaoA Uemura
Sep 19, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Boniface NamangalaChihiro Sugimoto
Nov 19, 2013·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Chuan-Mo LeeChau-Ting Yeh
Jan 1, 1996·Biotherapy·J A Georgiades, W R Fleischmann
Apr 2, 2016·Veterinary Immunology and Immunopathology·Stephen W MamberJoseph M Cummins
Dec 1, 1996·Immunology Today·F M Rollwagen, S Baqar
May 1, 1999·Journal of Autoimmunity·O S TargoniP V Lehmann
Feb 5, 2005·American Journal of Veterinary Research·Joseph M CumminsChad G Thompson
Oct 17, 2002·Annals of the New York Academy of Sciences·Olivier A E SparaganoMiguel Habela

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.